Mode
Text Size
Log in / Sign up
N/A N=56 Randomized Other

Mobile HIV Prevention App for Black Women

Mobile Phone Use · Hiv · Stigma, Social

Enrolled (actual)
56
Serious AEs
0.0%
Results posted
Mar 2026
Primary outcome: Primary: Retention Rate — 20; 24 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
in-the-kNOW mobile app (Behavioral); Control (Behavioral)
Age
Adult · 18+ yrs
Sex
Female
Sponsor
Emory University
Primary completion
Dec 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Retention Rate
20; 24
PRIMARY
App User Retention Rate
70.03
PRIMARY
System Usability Scale (SUS)
63.25
PRIMARY
Impact Scale
4.19
PRIMARY
Perceived Usefulness (PU) Scale
3.54
PRIMARY
Perceived Ease of Use (PEOU) Scale
3.69
SECONDARY
Number of Home Test Kits Ordered by Participants.
3
SECONDARY
Number of Participants Indicating Intention to Start PrEP
8; 12; 11; 9; 5; 5
SECONDARY
Number of Participants Who Agreed With Statements About PrEP Initiation
1; 2; 19; 18; 6; 8
SECONDARY
Number of Participant's Who Initiated PrEP Treatment
0; 0
SECONDARY
Number of Enrolled Participants by Recruiting Source
21; 16; 0; 0; 1; 0
SECONDARY
Number of Participants Reporting Smartphone Ownership
28; 28

Summary

Black women have a significantly higher risk of acquiring HIV compared to their non-Black counterparts. The purpose of this study is to refine and test a mobile HIV Prevention and Reproductive Health app developed specifically for Black women.

Eligibility Criteria

Inclusion Criteria

  • 18-44 years of age
  • Self-identify as Black
  • Assigned female at birth and identify as female
  • Individuals who qualify for Pre-Exposure Prophylaxis (PrEP) based on the Centers for Disease Control (CDC) criteria (for residence in high HIV incidence areas-reside in Fulton, Cobb, Gwinnett, or Dekalb counties)
  • Sexually active within the last 6 months
  • HIV-negative
  • Owner of an Android or IOS smartphone

Exclusion Criteria

  • Adults unable to consent
  • Individuals who are not yet adults (infants, children, teenagers)
  • Pregnant women
  • Prisoners
  • Cognitively impaired or Individuals with Impaired Decision-Making Capacity
  • Individuals who are not able to clearly understand English
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05080972). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search